103.71
price up icon0.20%   0.21
after-market アフターアワーズ: 104.00 0.29 +0.28%
loading
前日終値:
$103.50
開ける:
$103.42
24時間の取引高:
3.19M
Relative Volume:
1.09
時価総額:
$19.80B
収益:
$3.08B
当期純損益:
$-986.58M
株価収益率:
-19.50
EPS:
-5.3172
ネットキャッシュフロー:
$292.08M
1週間 パフォーマンス:
+0.35%
1か月 パフォーマンス:
+0.38%
6か月 パフォーマンス:
+87.17%
1年 パフォーマンス:
+120.38%
1日の値動き範囲:
Value
$103.22
$103.75
1週間の範囲:
Value
$103.10
$103.75
52週間の値動き範囲:
Value
$38.81
$103.75

Exact Sciences Corp Stock (EXAS) Company Profile

Name
名前
Exact Sciences Corp
Name
セクター
Healthcare (1110)
Name
電話
608-284-5700
Name
住所
5505 ENDEAVOR LANE, MADISON, WI
Name
職員
7,200
Name
Twitter
@exactsciences
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
EXAS's Discussions on Twitter

Compare EXAS vs TMO, DHR, IDXX, A, IQV

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
EXAS
Exact Sciences Corp
103.71 19.76B 3.08B -986.58M 292.08M -5.3172
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
509.97 186.47B 44.56B 6.72B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
198.80 138.25B 24.57B 3.60B 5.26B 5.051
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
610.45 48.44B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
116.64 32.52B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
178.55 29.61B 16.30B 1.36B 2.05B 7.8573

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-20 ダウングレード Mizuho Outperform → Neutral
2026-01-05 ダウングレード Evercore ISI Outperform → In-line
2025-04-10 開始されました Mizuho Outperform
2025-03-13 開始されました RBC Capital Mkts Sector Perform
2025-01-23 開始されました Barclays Overweight
2024-08-28 開始されました Wells Fargo Overweight
2024-06-27 開始されました Scotiabank Sector Outperform
2024-06-03 再開されました Jefferies Buy
2024-01-02 アップグレード The Benchmark Company Hold → Buy
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-10-10 アップグレード Piper Sandler Neutral → Overweight
2023-09-28 開始されました Bernstein Outperform
2023-08-02 ダウングレード The Benchmark Company Buy → Hold
2023-05-10 アップグレード Craig Hallum Hold → Buy
2023-05-05 開始されました UBS Neutral
2023-03-09 アップグレード Citigroup Neutral → Buy
2023-02-10 ダウングレード Credit Suisse Outperform → Neutral
2023-01-18 ダウングレード Raymond James Outperform → Mkt Perform
2022-10-19 ダウングレード Craig Hallum Buy → Hold
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Neutral
2021-11-03 ダウングレード Raymond James Strong Buy → Outperform
2021-07-29 繰り返されました BTIG Research Buy
2021-07-29 繰り返されました Canaccord Genuity Buy
2021-07-29 繰り返されました Oppenheimer Outperform
2021-07-29 繰り返されました Stifel Buy
2021-06-15 開始されました Raymond James Strong Buy
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Equal Weight
2021-01-28 開始されました Truist Buy
2020-10-29 ダウングレード UBS Buy → Neutral
2020-10-28 ダウングレード Citigroup Buy → Neutral
2020-10-08 再開されました BTIG Research Buy
2020-04-02 開始されました Evercore ISI Outperform
2020-01-10 再開されました BTIG Research Buy
2020-01-07 開始されました Citigroup Buy
2019-12-13 開始されました Dougherty & Company Buy
2019-11-15 開始されました Stifel Buy
2019-10-17 繰り返されました BofA/Merrill Buy
2019-10-01 再開されました Craig Hallum Buy
2019-09-26 開始されました Oppenheimer Outperform
2019-02-26 アップグレード Goldman Neutral → Buy
2018-10-09 開始されました UBS Buy
2018-09-05 再開されました The Benchmark Company Hold
2018-08-13 繰り返されました Canaccord Genuity Buy
2018-04-03 アップグレード BTIG Research Neutral → Buy
2018-01-29 開始されました Goldman Neutral
2018-01-08 繰り返されました The Benchmark Company Buy
2017-11-13 ダウングレード Robert W. Baird Outperform → Neutral
2017-11-01 ダウングレード BTIG Research Buy → Neutral
すべてを表示

Exact Sciences Corp (EXAS) 最新ニュース

pulisher
Mar 09, 2026

Exact Sciences stock hits 52-week high at 103.68 USD - Investing.com India

Mar 09, 2026
pulisher
Mar 06, 2026

Exact Sciences EHR Outreach Program Highlights Cologuard Growth And Valuation Debate - simplywall.st

Mar 06, 2026
pulisher
Mar 05, 2026

Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover - Stocktwits

Mar 05, 2026
pulisher
Mar 04, 2026

CSLLY or EXAS: Which Is the Better Value Stock Right Now? - Yahoo! Finance Canada

Mar 04, 2026
pulisher
Mar 04, 2026

Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year - BioSpace

Mar 04, 2026
pulisher
Mar 04, 2026

EXACT SCIENCES CORP (NASDAQ:EXAS) Shows Strong Technical and Fundamental Momentum - ChartMill

Mar 04, 2026
pulisher
Mar 04, 2026

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - BioSpace

Mar 04, 2026
pulisher
Mar 03, 2026

Exact Sciences Stock: Is The Post-Earnings Slide A Buying Setup for 2026? - AD HOC NEWS

Mar 03, 2026
pulisher
Mar 03, 2026

Exact Sciences (NASDAQ: EXAS) EVP exercises 3,900 options, 1,913 shares withheld - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Exact Sciences (EXAS) CEO reports RSU vesting and tax-withheld share dispositions - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

KeyCare, Inc. announced that it has received $27.4 million in funding from a group of investors - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Is Exact Sciences (EXAS) Pricing Reflect Long Term Cancer Screening Growth Potential - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

Exact Sciences Corporation $EXAS Shares Sold by Fox Run Management L.L.C. - MarketBeat

Mar 03, 2026
pulisher
Mar 01, 2026

EXAS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 01, 2026
pulisher
Feb 28, 2026

Pentwater Capital Management LP's Exact Sciences Corp(EXAS) Holding History - GuruFocus

Feb 28, 2026
pulisher
Feb 27, 2026

[Form 4] EXACT SCIENCES CORP Insider Trading Activity - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

EXACT Sciences (EXAS) HR EVP awarded 23,224 RSUs in new grant - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Exact Sciences (EXAS) grants SVP Herriott 20,321 restricted stock units - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

EXACT Sciences (EXAS) CEO receives major RSU grant and tax-share withholding - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Exact Sciences (EXAS) awards 28,063 restricted stock units to EVP Baranick - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Exact Sciences (NASDAQ: EXAS) EVP receives 38,707 restricted stock units - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval - Insider Monkey

Feb 27, 2026
pulisher
Feb 27, 2026

December 18th Options Now Available For EXACT Sciences (EXAS) - Nasdaq

Feb 27, 2026
pulisher
Feb 25, 2026

Market Outlook: Is Exact Sciences Corporation showing insider buyingJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 25, 2026

Abbott Labs Increases Dividends for 54 Years, Acquires Exact Sciences - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time - The Motley Fool

Feb 25, 2026
pulisher
Feb 25, 2026

Abbott offers $20B in notes to finance Exact Sciences acquisition - MassDevice

Feb 25, 2026
pulisher
Feb 25, 2026

Abbott Laboratories (ABT) sells $20B of notes to finance Exact Sciences acquisition - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

Exact Sciences stock hits 52-week high at $103.55 By Investing.com - Investing.com India

Feb 24, 2026
pulisher
Feb 23, 2026

Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal - Bloomberg

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott lines up one of the year's biggest bond sales at $20B - Crain's Chicago Business

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories Stock (ABT) Opinions on Exact Sciences Acquisition - Quiver Quantitative

Feb 23, 2026
pulisher
Feb 23, 2026

Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting - Yahoo Finance

Feb 23, 2026
pulisher
Feb 23, 2026

Exact Sciences (NASDAQ:EXAS) Hits New 52-Week HighTime to Buy? - MarketBeat

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott kicks off bond sale for Exact Sciences deal - Modern Healthcare

Feb 23, 2026
pulisher
Feb 23, 2026

Exact Sciences stock hits 52-week high at $103.55 - Investing.com

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories Commences 8-Part Bond Sale Tied to Exact Sciences Acquisition, Bloomberg Reports - marketscreener.com

Feb 23, 2026
pulisher
Feb 21, 2026

Exact Sciences shareholders approve merger with Abbott Laboratories By Investing.com - Investing.com Nigeria

Feb 21, 2026
pulisher
Feb 21, 2026

Exact Sciences (EXAS) Shareholders Approve Abbott Acquisition - GuruFocus

Feb 21, 2026
pulisher
Feb 20, 2026

Exact Sciences shareholders approve merger with Abbott Laboratories - Investing.com

Feb 20, 2026
pulisher
Feb 20, 2026

Exact Sciences stockholders approve acquisition by Abbott - marketscreener.com

Feb 20, 2026
pulisher
Feb 20, 2026

Exact Sciences shareholders approve Abbott acquisition - Investing.com

Feb 20, 2026
pulisher
Feb 20, 2026

Exact Sciences Shareholders Approve Acquisition by Abbott Laboratories - marketscreener.com

Feb 20, 2026
pulisher
Feb 20, 2026

Exact Sciences shareholders approve $105 per share Abbott acquisition - StreetInsider

Feb 20, 2026
pulisher
Feb 20, 2026

Exact Sciences Stockholders Approve Acquisition by Abbott - The Chronicle-Journal

Feb 20, 2026
pulisher
Feb 20, 2026

Exact Sciences Corp.: The Quiet Cancer-Test Stock Everyone’s Watching - AD HOC NEWS

Feb 20, 2026
pulisher
Feb 19, 2026

Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up - The Globe and Mail

Feb 19, 2026
pulisher
Feb 19, 2026

Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock - Yahoo Finance

Feb 19, 2026
pulisher
Feb 19, 2026

Aberdeen Group plc Increases Stock Position in Exact Sciences Corporation $EXAS - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

Exact Sciences Corporation $EXAS is Eagle Health Investments LP's 10th Largest Position - MarketBeat

Feb 18, 2026
pulisher
Feb 17, 2026

Assessing Exact Sciences (EXAS) Valuation After Strong Recent Share Price Momentum - Yahoo Finance

Feb 17, 2026

Exact Sciences Corp (EXAS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research DGX
$201.58
price up icon 1.19%
diagnostics_research LH
$273.61
price up icon 1.46%
diagnostics_research MTD
$1,248.62
price up icon 3.22%
$205.22
price up icon 3.58%
diagnostics_research WAT
$305.67
price up icon 1.03%
diagnostics_research IQV
$178.55
price up icon 2.33%
大文字化:     |  ボリューム (24 時間):